Mi Sook Jeong

Title: Mi Sook Jeong: Innovator in Hepatitis Diagnosis

Introduction

Mi Sook Jeong is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of medical diagnostics, particularly in the area of liver disease. Her innovative work focuses on developing tools for the early detection and monitoring of chronic hepatitis and liver fibrosis.

Latest Patents

Mi Sook Jeong holds a patent for a "Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof." This invention provides a rapid and easy method to test for initial liver disease. It specifically utilizes a monoclonal antibody for α1-acid glycoprotein, allowing for the diagnosis of progressive chronic hepatitis and liver fibrosis by measuring the concentration of asialo-α1-acid glycoprotein (AsAGP) in a sample. The kit is designed to determine the degree of liver disease from a blood sample using an immunochromatography strip.

Career Highlights

Throughout her career, Mi Sook Jeong has worked with various organizations, including Acebiomed, Inc. Her expertise in medical diagnostics has positioned her as a key figure in the development of innovative solutions for liver disease.

Collaborations

Mi Sook Jeong has collaborated with notable professionals in her field, including WangJo Cha and Hyunhyo Suh. These collaborations have further enhanced her research and development efforts in medical diagnostics.

Conclusion

Mi Sook Jeong's contributions to the field of hepatitis diagnosis exemplify her commitment to advancing medical technology. Her innovative patent reflects her dedication to improving healthcare outcomes for patients with liver disease.